0001627223-21-000042.txt : 20210830 0001627223-21-000042.hdr.sgml : 20210830 20210830185248 ACCESSION NUMBER: 0001627223-21-000042 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210827 FILED AS OF DATE: 20210830 DATE AS OF CHANGE: 20210830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shelton David C CENTRAL INDEX KEY: 0001645179 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 211224947 MAIL ADDRESS: STREET 1: C/O THE CHEMOURS COMPANY STREET 2: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19898 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2021-08-27 0 0001627223 Chemours Co CC 0001645179 Shelton David C C/O THE CHEMOURS COMPANY 1007 MARKET STREET WILMINGTON DE 19898 0 1 0 0 SVP, GC & Corp. Secretary Common Stock 2021-08-27 4 M 0 8689 18.45 A 72616.3979 D Common Stock 2021-08-27 4 S 0 8689 35 D 63927.3979 D Common Stock 2021-08-30 4 M 0 1065 18.45 A 64992.3979 D Common Stock 2021-08-30 4 S 0 1065 35 D 63927.3979 D Common Stock 71500 I By Trust Common Stock 492 I By Spouse Stock Option (Right to Buy) 18.45 2021-08-27 4 M 0 8689 0 D 2022-02-03 Common Stock 8689 10951 D Stock Option (Right to Buy) 18.45 2021-08-30 4 M 0 1065 0 D 2022-02-03 Common Stock 1065 9886 D The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021. Includes directly owned shares, restricted stock units, and dividend equivalent units. Shares were sold in multiple transactions at prices ranging from $35.00 to $35.01. Option award was granted on February 4, 2015 with vesting in three equal annual installments beginning February 4, 2016. /s/ Pauletta Brown, Attorney-in-Fact 2021-08-30